Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1996-05-06
1999-03-09
Travers, Russell
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
A61K 31495, A61K 3150
Patent
active
058801243
ABSTRACT:
Guanosine triphosphate pathway tetrahydrobiopterin synthesis antagonist and/or pterin salvage pathway tetrahydrobiopterin synthesis antagonists are administered to inhibit nitric oxide synthesis from arginine in vascular cells in a subject in need of such inhibition (e.g., for prophylactic or curative effect for endotoxin- or cytokine-induced hypotension or for restoration of vascular contractile sensitivity to pressor agents in the treatment of such hypotension). The tetrahydrobiopterin synthesis antagonist may be administered with .alpha..sub.1 -adrenergic agonist or with nitric oxide synthase inhibitor. The tetrahydrobiopterin synthesis antagonists are also administered to attenuate inflammation caused by induced nitric oxide production in immune cells. Unwanted counterproductive or side effects can be eliminated or ameliorated by administration additionally of levodopa with or without carbidopa and L-5-hydroxytryptophane.
REFERENCES:
patent: 3557106 (1971-01-01), Roch
patent: 4282217 (1981-08-01), Baglioni et al.
patent: 4328309 (1982-05-01), Chambers et al.
patent: 4670438 (1987-06-01), Austel et al.
patent: 4701455 (1987-10-01), Nichol et al.
patent: 4734438 (1988-03-01), Macri
patent: 5002944 (1991-03-01), Spada et al.
patent: 5028627 (1991-07-01), Kilbourn et al.
patent: 5030634 (1991-07-01), Krumdieck et al.
patent: 5059712 (1991-10-01), Griffith
patent: 5132453 (1992-07-01), Griffith
patent: 5158883 (1992-10-01), Griffith
patent: 5196195 (1993-03-01), Griffith
patent: 5216025 (1993-06-01), Gross et al.
patent: 5273875 (1993-12-01), Griffith
patent: 5281627 (1994-01-01), Griffith
patent: 5298506 (1994-03-01), Stamler et al.
patent: 5397778 (1995-03-01), Forse et al.
patent: 5449688 (1995-09-01), Wahl et al.
Patent Cooperation Treaty International Search Report for PCT/US90/05199, Oct. 29, 1991.
Stuehr, D.J., et al, Biochem. Biophys. Res. Commun. 161, 420-426 (1989).
Stuehr, D.J., et al, J. Exp. Med. 169, 1011-1020 (1989).
Rees, D.D., Proc. Natl. Acad. Sci. USA 86, 3375-3378 (1989).
Aisaka, K., et al, Biochem. Biophys. Res. Commun. 160, 881-886 (1989).
Natanson, C., et al, Journal of Exp. Med. 169, 823-832 (1989).
Schmidt, H., et al, Eur. J. Pharmacology, 154, 213-216 (1988).
Palmer, R.M.J., et al, Biochem. Biophys. Res. Commun. 153, 1251-1256 (1988).
Sakuma, I., et al, Proc. Natl. Acad. Sci. USA, 85, 8664-8667 (1988).
Palmer, R.M.J, et al, Nature, 333, 664-666 (1988).
Hibbs, J.B., et al, Biochem. Biophys. Res. Commun. 157, 87-94 (1988).
Marletta, M.A., et al, Biochemistry, 27, 8706-8711 (1988).
Palmer, R.M.J., et al, Nature, 327, 524-526 (1987).
Stuehr, D.J., et al, J. of Immunology, 139, 518-525 (1987).
Iyengar, R., et al, Proc. Nat'l. Acad. Sci. USA, 84, 6369-6373 (1987).
Turan, A., et al, Acta Chimica Academiae Scientiarum Hungaricae, 85, 327-332 (1975).
Kilbourn, R.G., et al, Proc. Nat'l. Acad. Sci. USA, 87, 3629-3632 (1990).
Kaufman, S., et al, J. Biol. Chem., 234, No. 10, 2683-2688 (Oct. 1959).
Kaufman, S., et al, J. Biol. Chem., 242, No. 17, 3934-3943 (Sep. 1967).
Kerler, F., et al, Exp. Cell Res., 189, 151-156 (1990).
Kwon, N.S., et al, J. Biol. Chem., 264, No. 34, 20496-20501 (Dec. 1989).
Milstien, S., et al, Biochem. Biophys. Res. Commun., 128, No. 3, 1099-1107 (May 1985).
Nichol, C., et al, Ann. Rev. Biochem. 54, 729-764 (1985).
Tayeh, M.A., et al, J. Biol. Chem., 264, No. 33, 19654-19658 (1989).
Ziegler, I., et al, J. Biol. Chem., 265, No. 28, 17026-17030 (Oct. 1990).
Marletta, M.A., "Nitric oxide: biosynthesis and biological significance," name of publication unknown, Elsevier Science Publishers, Ltd. (UK), pp. 448-453 (1989).
Book of Abstracts, Second International Meeting Biology of Nitric Oxide, cover page, meeting schedule page, abstract headed Synthesis of Tetrahydrobiopterin is a Requirement for Induction of Nitric Oxide Synthesis by LPS/Interferon in Vascular Smooth Muscle (Steven S. Gross and Robert Levi).
Werner, E., et al, Biochem. J., 262: 861-866 (1989).
Moncada, S., et al, Pharmacological Reviews 43(2): 109-142 (1991).
Gross, S.S., et al, Biochem. Biophys. Res. Commun. 170, 96-103 (Jul. 1990).
Gross, S.S., et al, J. Biol. Chem. 267, 25722-25729 (Dec. 1992).
Kilbourn, R.G., et al, Biochem. Biophys. Res. Commun. 172, 1132-1138 (Nov. 1990).
Kilbourn, R.G., et al, J. Nat'l. Cancer Inst. 84, 827-831 (Jun. 1992).
Moncada, S., et al, Eur. J. Clin. Invest. 21, 361-374 (1991).
Moncada, S., et al, Cardiovascular Pharm. 17 (suppl. 3), S1-S9 (1991).
Rees, D.D., et al, Br. J. Pharmacol., 96, 418-424 (1989).
Rees, D.D., et al, Nitric oxide from L-arginine: a bioregulatory system, S. Moncada, et al. ed., Elsevier Science Publishers, BV, 485-487 (1990).
Rees, D.D., et al, Chem. Abstr. 110: 112347q (1989).
Salvemini, D., et al, Chem. Abstr. 115: 204139e (1991).
Stuehr, D.J., et al, Advances in Enzymology, 65, 287-346 (1992).
Selye, H., Proc. Soc. Exper. Biol. & Med. 82, 328-333 (1953).
Selye, H., J. Am. Med. Assoc., 152, 1207-1213 (1953).
Kwon, N.S., et al, Chem. Abstr. 111: 230525q (1989).
Merck Index, 10th Ed., #s 1227 and 7834.
Vallance, P., et al, New Horizens 77-86 (Feb. 1993).
Aisaka, K., et al, Biochem. Biophys. Res. Commun., 163, No. 2, 710-717 (Sep. 14, 1989).
Kilbourn, R.G., et al, Journal of the National Cancer Institute, 84, No. 13, 1008-1016 (Jul. 1, 1992).
Jolou-Schaeffer, G., et al, Am. J. Physiol. 259, H1038-H1043, (Oct. 1990).
Gray, G.A., et al, Br. J. Pharmacol, 103, 1218-1224 (May 1991).
Bhattacharya, S.K., at al, Chemical Abstracts 106: 13424y (1987).
Corbett, J.A., et al, J. Clin. Invest. 90, 2384-2391 (1992).
Corbett, J.A., et al, Proc. Nat'l. Acad. Sci. USA, 90, 1731-1735 (Mar. 1993).
Ialenti, A., et al, Eur. J. Pharmacol., 211, 177-182 (1992).
Kleeman, R., et al, FEBS, 328, 9-12 (Aug. 1993).
McCartney-Francis, N., et al, J. Exp. Med. 178, 749-754 (1993).
Misko, T.P., et al, Eur. J. Pharmacol. 233, 119-125 (1993).
Corbett, J.A., et al, Proc. Nat'l. Acad. Sci. USA, 90, 8992-8995 (Oct. 1993).
Corbett, J.A., et al, Biochemistry 32, 13767-13770 (1993).
Kroncke, K.-D., et al, Biochem. Biophys. Res. Commun. 175, 752-758 (1991).
Lukic, M.L., et al, Biochem. Biophys. Res. Commun. 178, 913-920 (1991).
Mulligan, M.S., et al, Proc. Nat'l. Acad. Sci. USA, 88 6338-6342 (Jul. 1991).
Mulligan, M.S., et al, Br. J. Pharmacol. 107, 1159-1162 (1992).
Galivan, J., et al, Chemical Abstracts 106: 27532u (1987).
Zhang, L.X., et al, Chemical Abstracts 114: 55456f (1991).
Gross, S., et al, FASEB Journal 6, A1509 (1992).
Krumdieck, C.L., et al, Chemical Abstracts 115: 150382h (1991).
Nathan, C.F., et al, Current Opinion in Immunology, 3, 65-7 (1991).
Gross, S., J. Vasc. Res., 29, 125-126, Abstract 147 (1992).
Monache, F.D., et al, J. Chem. Soc. Perkin I, 3127-3131 (1979).
Roper, N., New Americal Pocket Medical Dictionary, 2nd Edition, p. 11, Charles Scribner's Sons, New York (1988).
Christen, S., et al, Chemical Abstracts 112: 233431n (1990).
Christen, S., et al, Proc. Nat'l. Acad. Sci. USA, 87, 2506-2510 (Apr. 1990).
Ziegler, I., et al, J. Biol. Chem., 265, No. 28, 17026-17030, (1990).
The Merck Index, 11th Edition, p. 488, #485, (1989).
Antonaccio et al 80 CA:149g 1974
Merck Manual 14th 1982 pp. 402-405.
Cornell Research Foundation Inc.
Travers Russell
LandOfFree
Blocking induction of tetrahydrobiopterin to block induction of does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Blocking induction of tetrahydrobiopterin to block induction of , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Blocking induction of tetrahydrobiopterin to block induction of will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1321355